Oral GLP-1 obesity drugs see rapid early adoption, Bernstein survey shows

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/28/2026

1. SPY
2. AKAM
3. COST
4. META
5. NVDA
6. ZS
7. DRI
8. ULS
9. CRL
10. VEON

Go back to Oral GLP-1 obesity drugs see rapid early adoption, Bernstein survey shows
(NASDAQ: GPCR) Delayed: 35.93 --0 (-0%)
Previous Close $35.93    52 Week High $ 
Open $35.93    52 Week Low $ 
Day High $35.93    P/E N/A 
Day Low $35.93    EPS $ 
Volume 20       

Lilly (Eli) & Co. (NYSE: LLY) Delayed: 1183.46 --0 (-0%)
Previous Close $1183.46    52 Week High $88.16 
Open $1183.46    52 Week Low $67.88 
Day High $1183.46    P/E 273.95 
Day Low $1183.46    EPS $4.32 
Volume 2,492       

NOVO-NORDISK A/S (NYSE: NVO) Delayed: 38.80 --0 (-0%)
Previous Close $38.80    52 Week High $59.00 
Open $38.80    52 Week Low $32.80 
Day High $38.80    P/E N/A 
Day Low $38.80    EPS $0.00 
Volume 89,711       

ING Van Kampen Equity Growth Fund S 2 Class (NASDAQ: VKTX) Delayed: 35.56 --0 (-0%)
Previous Close $35.56    52 Week High $5.17 
Open $35.56    52 Week Low $0.94 
Day High $35.56    P/E N/A 
Day Low $35.56    EPS $0.00 
Volume 9,900